I'm Dr. Michael Chichak, and as a physician dedicated to providing compassionate primary care and promoting health equity, I feel the study on CT colonography (CTC) really emphasizes the important difference between a treatment working in the lab (efficacy) and actually working for people in their daily lives (real-world effectiveness). To me, CTC looks like a better, more practical strategy for many individuals because it addresses adherence and structural barriers, not because it's clinically better than a colonoscopy itself. Traditional screening, while wonderful at catching cancer, can be quite difficult for people to manage. It involves sedation, time away from jobs, and organizing travel, and these things can, unfortunately, place a greater burden on people facing social or economic challenges, which can lead to fewer people completing the screening. The real advantage of CTC is that it's non-invasive, requires no sedation, and is a much quicker, easier process. The evidence gently suggests that when given a less disruptive choice like CTC, people are simply more willing to take that important step to get screened. By easing those big hurdles related to scheduling and inconvenience, CTC helps more people finish the screening process, which means we find and treat more cancers, ultimately moving us toward reducing health disparities.
The benefit to Black adults of CT colonography is that it is a more streamlined pathway through the screening process than would be the case during the traditional colonoscopy process. A number of Black adults are faced with conflicting demands such as managing work commitments and/or caring for family members; therefore, they are less likely to be able to take time from their busy lives to attend for an appointment to undergo screening. Additionally, CTC will remove some of the barriers to the screening process many people face. The test is shorter in duration compared to colonoscopy and thus there is less risk of complications than colonoscopy and the patient does not need to be sedated before undergoing the test and so can quickly return to their daily routine. Therefore, when a test is an integral part of daily life rather than conflicting with it adherence improves and ultimately, better results are achieved in the long-term. An additional factor supporting the use of CTC is that it can detect the lesions in the colon in which Black adults have more aggressive disease on those areas of the colon that are more difficult to examine using flexible scope technology. The complete picture with close-up images offered by CTC promises to detect earlier on, especially those Black adults that historically have had less opportunity to get screened or have been screened at an older age. Thus, integrating easy access to screening with the full and accurate imaging capabilities of CTC is assisting a screening strategy with the aim of helping to eliminate the significant disparities in outcomes.